SCHEMBL6166496

SCHEMBL6166496

CCN(CC)C(=O)C(N)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.59
PKM P14618 1/20 0.59
PTGS1 P23219 1/20 0.59
XIAP P98170 1/20 0.59
SLC7A5 Q01650 1/20 0.59
SLC15A1 P46059 1/20 0.51
MC4R P32245 4/20 0.51
MC5R P33032 3/20 0.51
MC3R P41968 3/20 0.51
LMNA P02545 1/20 0.50
LTA4H P09960 1/20 0.49
SLC1A3 P43003 2/20 0.47
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
HDAC8 Q9BY41 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SLC6A2 P23975 2/20 0.46
TAAR1 Q96RJ0 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9200374 1.00 ALPI (0.59) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL9872582 0.87 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2015825 0.85 SLC7A5 (0.59) SLC7A5MC4RMC5RMC3RHDAC8
SCHEMBL2015826 0.85 SLC7A5 (0.59) SLC7A5MC4RMC5RMC3RHDAC8
SCHEMBL26518995 0.85 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL26871861 0.84 ALPI (0.46) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL5605249 0.84 SLC7A5 (0.61) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL24785636 0.84 MC4R (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL1764633 0.82 ALPI (0.63) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL30959049 0.82 ALPI (0.63) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0495013-B1 HEXAPEPTIDES WITH SULPHATE ESTER GROUPS FISONS CORP (US) 1995-03-08 EP disclosed
EP-0226217-B1 Peptides with sulfate ester group FISONS CORP (US) 1994-01-26 EP disclosed
EP-0495013-A1 HEXAPEPTIDES WITH SULPHATE ESTER GROUPS. FISONS CORP (US) 1992-07-22 EP disclosed
WO-1991008225-A1 HEXAPEPTIDES WITH SULPHATE ESTER GROUPS FISONS CORPORATION (US) 1991-06-13 WO disclosed